Ischaemic preconditioning: Present position and future directions

Cardiovascular Research

Volumn 37, Issue 1, 1998, Pages 21-33

  Yellon, Derek M ^a   Baxter, Gary F ^a   Garcia Dorado, David ^b   Heusch, Gerd ^c   Sumeray, Mark S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Ischemic preconditioning; Myocardial protection; Myocardium

Indexed keywords

ADAPTATION; CELL METABOLISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HUMAN; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; POTASSIUM CHANNELS; PROTEIN KINASE C; RECEPTORS, PURINERGIC P1; RESEARCH; SIGNAL TRANSDUCTION;

EID: 0031912483     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00214-9     Document Type: Review

References (136)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Reimer K.A., Murry C.E., Yamasawa I, Hill M.L., Jennings R.B. Four brief periods of ischaemia cause no cumulative ATP loss or necrosis. Am J Physiol. 251:1986;H1306-1315.
3. Cohen M.V., Walsh R.S., Goto M., Downey J.M. Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release. J Mol Cell Cardiol. 27:1995;1527-1534.
4. Mei D.A., Gross G.J. Evidence for the involvement of the ATP-sensitive potassium channel in a novel model of hypoxic preconditioning in dogs. Cardiovasc Res. 30:1995;222-230.
5. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res. 77:1995;1030-1035.
6. Armstrong S., Downey J.M., Ganote C.E. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res. 28:1994;72-77.
7. Cave A.C. Preconditioning induced protection against post-ischaemic contractile dysfunction: characteristics and mechanisms. J Mol Cell Cardiol. 27:1995;969-979.
8. Ovize M., Przyklenk K., Hale S.L., Kloner R.A. Preconditioning does not attenuate myocardial stunning. Circulation. 85:1992;2247-2254.
9. Hagar J.M., Hale S.L., Kloner R.A. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res. 68:1991;61-68.
10. Ovize M., Aupetit J.F., Rioufol G., Loufoua J., Andre Fouet X., Minaire Y., Faucon G. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol. 269:1995;H72-79.
11. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
12. Schott R.J., Rohmann S., Braun E.R., Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 66:1990;1133-1142.
13. Thornton J., Striplin S., Liu G.S., Swafford A., Stanley A.W., Van Winkle D.M., Downey J.M. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol. 259:1990;H1822-1825.
14. Mullane K., Bullough D. Harnessing an endogenous cardioprotective mechanism:cellular sources and sites of action of adenosine. J Mol Cell Cardiol. 27:1995;1041-1054.
15. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res. 73:1993;1193-1201.
16. Yao Z., Gross G.J. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol. 264:1993;H2221-2225.
17. Banerjee A., Locke Winter C., Rogers K.B., Mitchell M.B., Brew E.C., Cairns C.B., Bensard D.D., Harken A.H. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res. 73:1993;656-670.
18. Liu Y., Tsuchida A., Cohen M.V., Downey J.M. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 27:1995;883-892.
19. Goto M., Liu Y., Yang X.M., Ardell J.L., Cohen M.V., Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
20. Erikson J.M., Velasco C.E. Endothelin-1 and myocardial preconditioning. Am Heart J. 132:1996;84-90.
21. Schultz J.E., Hsu A.K., Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 78:1996;1100-1104.
22. Li Y., Kloner R.A. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation. 87:1993;1642-1648.
23. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 264:1993;H1327-1336.
24. Schulz R., Rose J., Post H., Heusch G. Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch. 430:1995;273-282.
25. Walker D.M., Walker J.M., Pugsley W.B., Pattison C.W., Yellon D.M. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 27:1995;1349-1357.
26. Li Y., Kloner R.A. Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids. Cardiovasc Res. 26:1992;226-231.
27. Vegh A., Szekeres L., Parratt J.R. Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res. 24:1990;1020-1023.
28. 2 receptor activation in human heart. JACC. 29:1997;1599-1606.
29. Thornton J.D., Thornton C.S., Downey J.M. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol. 265:1993;H504-508.
30. Thornton J.D., Liu G.S., Downey J.M. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol. 25:1993;311-320.
31. Downey J.M., Cohen M.V. Signal transduction in ischemic preconditioning. Z Kardiol. 4:1995;77-86.
32. Ytrehus K., Liu Y., Downey J.M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 266:1994;H1145-1152.
33. Kitakaze M., Node K., Minamino T., Komamura K., Funaya H., Shinozaki Y., Chujo M., Mori H., Inoue M., Hori M., Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation. 93:1996;781-791.
34. Liu Y., Cohen M.V., Downey J.M. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts [letter]. Cardiovasc Drugs Ther. 8:1994;881-882.
35. Speechly Dick M.E., Mocanu M.M., Yellon D.M. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res. 75:1994;586-590.
36. Przyklenk K., Sussman M.A., Simkhovich B.Z., Kloner R.A. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 92:1995;1546-1557.
37. Vahlhaus C., Schulz R., Post H., Onallah R., Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res. 79:1996;407-414.
38. + exchange. J Mol Cell Cardiol. 20:1988;493-500.
39. Black S.C., Phagbemi S.O., Chi L., Friedrichs S., Lucchesi B.R. Phorbol-ester induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide. J Mol Cell Cardiol. 25:1993;1427-1438.
40. Brooks G., Hearse D.J. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res. 79:1996;627-630.
41. Baines C.P., Cohen M.V., Downey J.M. Protein tyrosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts. Circulation. 94(Suppl. I):1996;I-661.
42. Ferdinandy P., Szilvassy Z., Koltai M., Dux L. Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts. J Cardiovasc Pharmacol. 25:1995;97-104.
43. Armstrong S.C., Liu G.S., Downey J.M., Ganote C.E. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol. 27:1995;1765-1774.
44. Walsh R.S., Tsuchida A., Daly J.J., Thornton J.D., Cohen M.V., Downey J.M. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res. 28:1994;1337-1341.
45. Auchampach J.A., Grover G.J., Gross G.J. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 26:1992;1054-1062.
46. Koning M.M., Gho B.C., van Klaarwater E., Opstal R.L., Duncker D.J., Verdouw P.D. Rapid ventricular pacing produces myocardial protection by nonischemic activation of KATP channels. Circulation. 93:1996;178-186.
47. Schulz R., Rose J., Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 267:1994;H1341-1352.
48. Mizumura T., Nithipatikom K., Gross G.J. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 92:1995;1236-1245.
49. Yao Z., Gross G.J. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol. 267:1994;H1888-1894.
50. Stiles G. Adenosine receptors: physiological regulation and biochemical mechanisms. News in Physiological Sciences. 6:1991;161-164.
51. + channels. Circ Res. 79:1996;399-406.
52. + current by protein kinase C and adenosine. Circ Res. 78:1996;443-454.
53. Yao Z., Gross G.J. Effects of KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 89:1994;1769-1775.
54. Murry C.E., Jennings R.B., Reimer K.A. New insights into potential mechanisms of ischemic preconditioning. Circulation. 84:1991;442-445.
55. Ganote C., Armstrong S.E. Ischaemia and the myocyte cytoskeleton: review and speculation. Cardiovasc Res. 27:1993;1387-1403.
56. Ovize M., Przyklenk K., Kloner R.A. Partial coronary stenosis is sufficient and complete reperfusion is mandatory for preconditioning the canine heart. Circ Res. 71:1992;1165-1173.
57. Koning M.M., Simonis L.A., de Zeeuw S., Nieukoop S., Post S., Verdouw P.D. Ischaemic preconditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res. 28:1994;1146-1151.
58. Schulz R., Post H., Sakka S., Wallbridge D.R., Heusch G. Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. Circ Res. 76:1995;942-950.
59. Kida M., Fujiwara H., Ishida M., Kawai C., Ohura M., Miura I., Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.
60. Van Wylen D.G. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation. 89:1994;2283-2289.
61. Wolfe C.L., Sievers R.E., Visseren F.L., Donnelly T.J. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 87:1993;881-892.
62. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanism of preconditioning. Ionic alterations. Circ Res. 72:1993;112-125.
63. Sanz E., Garcia Dorado D., Oliveras J., Barrabes J.A., Gonzalez M.A., Ruiz Meana M., Solares J., Carreras M.J., Garcia Lafuente A., Desco M.et al. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning. Am J Physiol. 268:1995;H233-241.
64. + exchange in ischemia-reperfusion. Cardiovasc Res. 91:1996;191-202.
65. Bugge E., Ytrehus K. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protection additive to ischaemic preconditioning. Cardiovasc Res. 29:1995;269-274.
66. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 87:1993;893-899.
67. Gho B.C., Shoemaker R.G., van den Doel M.A., Duncker D.J., Verdouw P.D. Myocardial protection by brief ischemia in non-cardiac tissue. Circulation. 94:1996;2193-2200.
68. Ovize M., Kloner R.A., Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol. 266:1994;H137-146.
69. Gysembergh A., Margonari H., Andre-Fouet X., Minaire Y., Ovize M. Stretch-induced preconditioning is mediated by protein kinase C in the rabbit heart. Circulation. 94(Supp. I):1996;I-392. Abstract.
70. Mounsey R.A., Pang C.Y., Boyd J.B., Forrest C. Augmentation of skeletal muscle survival in the latissimus dorsi porcine model using acute ischemic preconditioning. J Otolaryngol. 21:1992;315-320.
71. Pang C.Y., Yang R.Z., Zhong A., Xu N., Boyd B., Forrest C.R. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 29(6):1995;782-788.
72. 1 receptors in acute ischaemic preconditioning against skeletal muscle infarction. Can J Physiol Pharmacol. 72:1994;146. Abstract.
73. Jerome S.N., Akimitsu T., Gute D.C., Korthuis R.J. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol. 268:1995;H2063-2067.
74. Liu Y., Kato H., Nakata N., Kogure K. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res. 586:1992;121-124.
75. Heurteaux C., Lauritzen I., Widmann C., Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive potassium channels in cerebral ischaemic preconditioning. Proc Nat Acad Sci USA. 92:1995;4666-4670.
76. Millar C.G.M., Woolfson R.G., Unwin R.J., Neild G.H. Ischaemic preconditioning does not protect the kidney from ischaemia reperfusion injury. Nephrol Dial Transplant. 10:1995;736.
77. Joannidis M., Cantley L.G., Spokes K., Medina R., Pullman J., Rozen S., Epstein F.H. Induction of heat shock proteins does not prevent renal tubular injury following ischemia. Kidney Int. 47:1995;1752-1759.
78. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., Kamada T., Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 72:1993;1293-1299.
79. Baxter G.F., Marber M.S., Patel V.C., Yellon D.M. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 90:1994;2993-3000.
80. Baxter G.F., Goma F.M., Yellon D.M. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 92:1997;159-167.
81. Baxter G.F., Goma F.M., Yellon D.M. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 115:1995;222-224.
82. Node K., Hasegawa M., Suzuki S., Hori M. Induction of ecto-5′-nucleotidase contributes to the second-window of cardioprotection in ischemic preconditioning. Circulation. 94:1996;I-422.
83. Yang X.M., Baxter G.F., Heads R.J., Yellon D.M., Downey J.M., Cohen M.V. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res. 31:1996;777-783.
84. Yamashita N., Kuzuya T., Hoshida S., Nishida M., Igarishi J., Hori M., Kamada T., Tada M. A "second window of protection" occurs 24 hours after ischaemic preconditioning in rat heart. J Mol Cell Cardiol. 27:1995;A517. Abstract.
85. Kaeffer N., Richard V., Thuillez C. Delayed beneficial effects of pre-conditioning against reperfusion-induced coronary endothelial dysfunction. Evidence for a 'second window' of protection. Eur Heart J. 17:1996;268.
86. Vegh A., Papp J.G., Parratt J.R. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol. 113:1994;1081-1082.
87. Kaszala K., Vegh A., Papp J.G., Parratt J.R. Time course of the protection against ischaemia- and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing. J Mol Cell Cardiol. 28:1996;2085-2095.
88. Sun J.Z., Tang X.L., Knowlton A.A., Park S.W., Qiu Y., Bolli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 95:1995;388-403.
89. Tang X.L., Qiu Y., Sun J.Z., Park S.W., Kalya A., Bolli R. Time-course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 79:1996;424-434.
90. Qiu Y., Maldonado C., Tang X.L., Bolli R. Late preconditioning against myocardial stunning in conscious rabbits. Circulation. 92(Suppl.):1995;I-717. Abstract.
91. Yamashita N., Nishida M., Hoshida S., Kuzuya T., Hori M., Taniguchi N., Kamada T., Tada M. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest. 94:1994;2193-2199.
92. Cumming D.V.E., Heads R.J., Brand N.J., Yellon D.M., Latchman D.S. The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes. Basic Res Cardiol. 91:1996;79-85.
93. Tanaka M., Fujiwara H., Yamasaki K., Miyamae M., Yokota R., Hasegawa K., Fujiwara T., Sasayama S. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits. Am J Physiol. 267:1994;H1476-1482.
94. Strasser R., Arras M., Vogt A., Elsasser A., Schwarz E.R., Schlepper M., Schaper W. Preconditioning of porcine myocardium: how much ischemia is required for induction? What is its duration? Is a renewal of effect possible? Circulation. 90(Suppl.):1994;I-109. Abstract.
95. Qiu Y., Tang X.L., Park S.W., Sun J.Z., Kalya A., Bolli R. The early and late phases of ischemic preconditioning. A comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res. 80:1997;730-742.
96. Jagasia D., Whiting J.M., Mc Nulty P.H. Ischemic preconditioning fails to produce a second window of protection 24 hours later in the rat. Circulation. 94(Suppl):1996;I184-I185. Abstract.
97. Baxter G.F., Yellon D.M. Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit. J Cardiovasc Pharmacol. 29:1997;. In press.
98. Baxter G.F., Zaman M.J.S., Kerac M., Yellon D.M. Protection against global ischemia in the rabbit isolated heart 24 hours after transient adenosine A1 receptor activation. Cardiovasc Drug Ther. 11:1997;83-85.
99. Sun J.Z., Tang X.L., Park S.W., Qiu Y., Turrens J.F., Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 97:1996;562-576.
100. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., Jadoon A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997;42-52.
101. + channels mediated the cardioprotective effect of monophosphoryl lipid A. Circulation. 92(Suppl.):1995;I-388. abstract.
102. Wilson S., Song W., Kaszala K., Ravingerova T., Vegh A., Papp J., Tomisawa S., Parratt J.R., Pyne N.J. Delayed cardioprotection is associated with the sub-cellular relocalisation of ventricular protein kinase C-ε, but not p42/44MAPK. Mol Cell Biochem. 160/161:1996;225-230.
103. Ping P., Zhang J., Qiu Y., Tang X.L., Manchikalapudi S., Bolli R. Repetitive episodes of myocardial ischemia and reperfusion induce translocation of protein kinase C epsilon isoform in conscious rabbits which is associated with late preconditioning against myocardial stunning. Circulation. 94(Suppl.):1996;I-660. Abstract.
104. Ping P., Xang J., Qiu Y., Tang X.L., Manchikalapudi S., Kalya A., Cao X., Bolli R. Chelerythrine abolishes the translocation of PKC e and (isoforms induced by ischemic preconditioning in conscious rabbits. J Mol Cell Cardiol. 29:1997;A231. Abstract.
105. Imagawa J., Baxter G.F., Yellon D.M. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 hours after ischemic preconditioning in the rabbit. J Mol Cell Cardiol. 29:1997;1885-1893.
106. Dana A, Baxter GF, Yellon DM, Both protein kinase C and protein tyrosine kinase mediate adenosine induced delayed cardioprotection in rabbits. Circulation 1997, abstract in press.
107. Maulik N., Watanabe M., Zu Y.L., Huang C.K., Cordis G.A., Schley J.A., Das D.K. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Letters. 396:1996;233-237.
108. Knight R.J., Buxton D.B. Stimulation of c-jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun. 218:1996;83-88.
109. Bogoyevitch M.A., Gillespie-Brown J., Ketterman A.J. Stimulation of the stress-activated mitogen-activated protein kinase sub families in perfused heart. p38/RK mitogen-activated protein kinases and c-jun n-terminal kinases are activated by ischemia/reperfusion. Circ Res. 79:1996;162-173.
110. Hoshida S., Kuzuya T., Fuji H., Yamashita N., Oe H., Hori M., Suzuki K., Taniguchi N., Tada M. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol. 264:1993;H33-39.
111. Heads R.J., Latchman D.S., Yellon D.M. Stable high level expression of a transfected human HSP70 gene protects a heart-derived muscle cell line against thermal stress. J Mol Cell Cardiol. 26:1994;695-699.
112. Mestril R., Chi S.H., Sayen M.R., O'Reilly K., Dillmann W.H. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Invest. 93:1994;759-767.
113. Marber M.S., Mestril R., Chi S.H., Sayen M.R., Yellon D.M., Dillmann W.H. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest. 95:1995;1446-1456.
114. Ikonomidis J.S., Tumiati L.C., Weisel R.D., Mickle D.A., Li R.K. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res. 28:1994;1285-1291.
115. Kloner R.A., Shook T., Przyklenk K., Davis V.G., Junio L., Matthews R.V., Burstein S., Gibson M., Poole W.K., Cannon C.P.et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 91:1995;37-45.
116. Marber M.S., Joy M.D., Yellon D.M. Is warm-up in angina ischaemic preconditioning? [editorial]. Br Heart J. 72:1994;213-215.
117. + channel blocker. Circulation. 90:1994;700-705.
118. Baxter G.F. Coronary angioplasty as a model of ischaemic preconditioning: fact or fancy? Eur Heart J. 17:1996;812-814.
119. Yellon D.M., Alkulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
120. Jenkins D.P., Pugsley W.B., Kemp M., Hooper J., Yellon D.M. Ischaemic preconditioning reduces troponin-T release in patients undergoing cardiac surgery. Heart. 77:1997;314-318.
121. Tsuchida A., Thompson R., Olsson R.A., Downey J.M. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart. J Mol Cell Cardiol. 26(3):1994;303-311.
122. Dana A., Baxter G.F., Walker J.M., Yellon D.M. Prolonging the delayed phase of cardioprotection by repetitive adenosine A1 receptor activation. J Mol Cell Cardiol. 29:1997;A67. Abstr.
123. Katus H.A., Schoeppenthau M., Tanzeem A., Bauer H.G., Saggau W., Diederich K.W., Hagl S., Kuebler W. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin-T. Br Heart Journal. 65:1991;259-264.
124. Hake U., Schmid F.X., Iversen S., Dahm M., Mayer E., Hafner G., Oelert H. Troponin-T - a reliable marker of perioperative myocardial infarction? Eur J Cardiothorac Surg. 7:1993;628-633.
125. Mair J., Wieser C., Seibt I., Artner-Dworazak E., Furtwangler W., Waldenberger F., Balogh D., Puschendorf B. Troponin-T to diagnose myocardial infarction in bypass surgery (letter). Lancet. 337:1991;434-435.
126. Opie L.H. Cardiac metabolism - emergence, decline, and resurgence. Part 2. Cardiovasc Res. 26:1992;817-830.
127. Vegh A., Szekeres L., Parratt J.R. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol. 107:1992;648-652.
128. Paratt J.R. Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc Res. 27:1993;693-702.
129. Wainwright C.L., Parratt J.R., vanBelle H. The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetised pigs. Br J Pharmacol. 109:1993;592-599.
130. Itoya M., Miura T., Urabe K., Ishimoto R., Iimura O. Nucleoside transport inhibitors enhance the infarct size limiting effect of preconditioning. Circulation. 86(Suppl.I):1992;I-125. Abstract.
131. Parratt J.R. Cardioprotection by angiotensin converting enzyme inhibitors - the experimental evidence. Cardiovasc Res. 28:1994;183-189.
132. Eldar M., Hollander G., Schulhoff N., Ohlstein E., Greengart A., Lichstein E., Shani J. Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery. Am J Cardiol. 70:1992;1621-1623.
133. 2-kinin receptors in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther. 252:1990;581-585.
134. Brady A.J., Warren J.B., Poole-Wilson P.A., Williams T.J., Harding S.E. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 265:1993;H176-182.
135. Szekeres L., Pataricza J., Szilvassy Z., Udvary E., Vegh A. Cardioprotection: endogenous protective mechanisms promoted by prostacyclin. Basic Res Cardiol. 87:1992;215-221.
136. Liu Y., Romashko D., O'Rourke B., Marban E. Mitochondrial KATP channels: novel effectors of cardioprotection? J Mol Cell Cardiol. 29:1997;A218. Abstract.